GeoVax Labs Files 8-K: Corporate Details Updated
Ticker: GOVX · Form: 8-K · Filed: Dec 18, 2024 · CIK: 832489
Sentiment: neutral
Topics: corporate-filing, 8-k
TL;DR
GeoVax Labs filed an 8-K updating corporate info. Nothing major, just housekeeping.
AI Summary
GeoVax Labs, Inc. filed an 8-K on December 18, 2024, reporting an event under 'Other Events'. The filing details the company's incorporation in Delaware, its IRS number, and its business address in Smyrna, GA. It also lists previous company names and dates of name changes.
Why It Matters
This filing provides updated corporate information for GeoVax Labs, Inc., which is important for investors and stakeholders to have the most current details about the company's structure and history.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain information about significant financial events, acquisitions, or legal issues.
Key Numbers
- 001-39563 — Commission File Number (Identifies the company's SEC filing history)
- 87-0455038 — IRS Employee Identification No. (Company's tax identification number)
Key Players & Entities
- GeoVax Labs, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Smyrna, GA (location) — Business address
- DAUPHIN TECHNOLOGY INC (company) — Former company name
- SUCCESSO INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for GeoVax Labs, Inc.?
The primary purpose is to report an event under 'Other Events', primarily updating corporate information such as its state of incorporation, IRS number, and business address.
When was the earliest event reported in this filing?
The earliest event reported was on December 18, 2024.
In which state is GeoVax Labs, Inc. incorporated?
GeoVax Labs, Inc. is incorporated in Delaware.
What is the business address of GeoVax Labs, Inc.?
The business address is 1900 Lake Park Drive, Suite 380, Smyrna, GA 30080.
Has GeoVax Labs, Inc. operated under previous names?
Yes, the company previously operated under the names DAUPHIN TECHNOLOGY INC and SUCCESSO INC, with name changes occurring on October 2, 2006, and April 10, 1991, respectively.
Filing Stats: 715 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-12-18 16:09:55
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share GOVX The Nasdaq Capital M
Filing Documents
- govx20241218_8k.htm (8-K) — 25KB
- 0001437749-24-037842.txt ( ) — 170KB
- govx-20241218.xsd (EX-101.SCH) — 4KB
- govx-20241218_def.xml (EX-101.DEF) — 13KB
- govx-20241218_lab.xml (EX-101.LAB) — 17KB
- govx-20241218_pre.xml (EX-101.PRE) — 13KB
- govx20241218_8k_htm.xml (XML) — 5KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K and other reports filed by the Company from time to time with the Securities and Exchange Commission (collectively the "Filings") contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company's management as well as estimates and assumptions made by the Company's management. When used in the Filings the words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan" or the negative of these terms and similar expressions as they relate to the Company or the Company's management identify forward looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Company's industry, operations and results of operations and any businesses that may be acquired by the Company. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Except as required by law, the Company does not undertake to update its forward-looking statements.
01 Other Events
Item 8.01 Other Events. The Company re-convened a Special Meeting of Stockholders (the "Special Meeting") on December 18, 2024 (originally convened on September 17, 2024) and adjourned the Special Meeting without any business being conducted due to lack of the required quorum. The Company has determined to keep the polls open and reconvene the Special Meeting on January 22, 2025 at 8:30 a.m. Eastern Time to provide its stockholders additional time to vote on the proposals described in the proxy statement filed with the Securities and Exchange Commission on August 1, 2024. No changes have been made to the proposals to be voted on by stockholders at the Special Meeting. At the time the Special Meeting was adjourned, proxies had been submitted by stockholders representing approximately 32.2% of the shares of the Company's common stock outstanding and entitled to vote. Proxies previously submitted in respect of the Special Meeting will be voted at the reconvened Special Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 18, 2024 GEOVAX LABS, INC. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer 2